Medtronic’s real problem is innovation, not taxation

The medical-device company has shifted from engineering to financial engineering, writes Tim Mullaney.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.